AII-Antagonisten - Atherosklerose
Figure 1: Changes in eNOS concentrations in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value (= 100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan)


Keywords: Angiotensin II,  Angiotensin II,  Candesartan,  Candesartan,  Diagramm,  Endothel,  endothelium,  eNOS,  eNOS,  Valsartan,  Valsartan

AII-Antagonisten - Atherosklerose
Figure 2: Changes in endothelin concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan)


Keywords: Angiotensin II,  Angiotensin II,  Candesartan,  Candesartan,  Diagramm,  endothelin,  endothelin,  Valsartan,  Valsartan

AII-Antagonisten - Atherosklerose
Figure 3: Changes in PAI-1 concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan)


Keywords: Angiotensin II,  Angiotensin II,  Candesartan,  Candesartan,  Diagramm,  PAI-1,  PAI-1,  plasminogen activator inhibitor,  Plasminogenaktivatorinhibitor,  Valsartan,  Valsartan

AII-Antagonisten - Atherosklerose
Figure 4: Changes in pro-MMP-1 concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan)


Keywords: Angiotensin II,  Angiotensin II,  Candesartan,  Candesartan,  Diagramm,  matrix-metalloproteinase,  Matrixmetalloproteinase,  pro-MMP-1,  pro-MMP-1,  Valsartan,  Valsartan

AII-Antagonisten - Atherosklerose
Figure 5: Changes in cell number of human coronary artery smooth muscle cells after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II: angiotensin II; Can: candesartan; Val: valsartan)


Keywords: Angiotensin II,  Angiotensin II,  Candesartan,  Candesartan,  Diagramm,  Glatte Muskelzelle,  smooth muscle cell,  Valsartan,  Valsartan